The Centers for Medicare & Medicaid Services Aug. 7 released a procedural notice on its new pathway to expedite access to certain FDA-designated Class II and Class III devices for Medicare beneficiaries.
Headline
The latest stories from AHA Today.
Guidance on the implementation timeline for the No Surprises Act independent dispute resolution operations final rule was released Aug. 7 by the Departments of Labor, Health and Human Services, and the Treasury, along with the Office of Personnel Management.
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus.
The Food and Drug Administration Aug. 5 approved the first mRNA-based flu vaccine, called mFlusiva.
The AHA will host a webinar Aug. 19 at 1 p.m. ET on how to implement behavioral threat assessment and management programs to address workforce violence risks, align cross-functional teams, establish workflows and intervene early to better protect patients, staff and visitors across systems.
The AHA’s Hospital Capacity Management Consortium will host a webinar Aug. 12 at 1 p.m. ET on how virtual nursing models can improve hospital throughput, reduce length of stay, increase bedside nursing capacity and support better patient outcomes.
The Centers for Disease Control and Prevention yesterday announced that the ongoing cyclosporiasis outbreak linked to iceberg lettuce has expanded to 15 states.
The AHA Aug. 5 provided comments to the Centers for Medicare & Medicaid Services on the distribution of funding for the Rural Health Transformation Program. The program will fund $50 billion to rural providers from fiscal year 2026 to FY 2030.
The Senate Aug. 5 voted 51-44 to confirm Erica Schwartz as the new director of the Centers for Disease Control and Prevention. Schwartz was previously deputy surgeon general during the first Trump administration.
A bipartisan group of senators Aug. 5 introduced the Supporting Underserved and Strengthening Transparency, Accountability and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act), a bill aimed at providing statutory clarity for the 340B Drug Pricing Program while establishing new…